[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370391-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370391-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","synergistic-effect-of-ribitol-and-shikonin-promotes-apoptosis-in-breast-cancer-cells","Synergistic Effect of Ribitol and Shikonin Promotes Apoptosis in Breast Cancer Cells","","The mortality rate of breast cancer remains high despite advances in chemotherapy, motivating the search for new treatments. This study tested whether ribitol, a metabolite, enhances shikonin’s cytotoxic action against breast cancer cells in vitro. A small-molecule screen showed significant drug synergy, increasing apoptotic cells and suppressing proliferation in the combined group. Mechanisms included p53 upregulation and reduced c-Myc and anti-apoptotic proteins. Metabolomic results suggest Warburg-effect inhibition, with ribitol disturbing glycolysis and the TCA cycle.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/synergistic-effect-of-ribitol-and-shikonin-promotes-apoptosis-in-breast-cancer-cells/370391/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/synergistic-effect-of-ribitol-and-shikonin-promotes-apoptosis-in-breast-cancer-cells/370391.png","ImageObject",300,407,{"name":42,"@type":43},"Genevieve","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main goal of the study?","Question",{"text":63,"@type":64},"The study aimed to determine whether ribitol enhances the cytotoxic effect of shikonin against breast cancer cells in vitro and to assess the underlying mechanism of this synergy.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What evidence of synergy was reported?",{"text":68,"@type":64},"The combined ribitol and shikonin treatment significantly increased apoptosis percentages compared with shikonin alone and produced marked growth arrest relative to untreated cells.",{"name":70,"@type":61,"acceptedAnswer":71},"Which molecular and metabolic changes were associated with the treatment?",{"text":72,"@type":64},"The study linked the effect to increased p53, decreased c-Myc and anti-apoptotic proteins such as Bcl-xL and Mcl-1, and metabolomic support for Warburg-effect inhibition alongside altered glycolysis and TCA cycle activity.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370391,1790743030,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Article  \nSynergistic Effect of Ribitol and Shikonin Promotes Apoptosis in Breast Cancer Cells  \nRavi Doddapaneni *, Jason D. Tucker , Pei J. Lu and Qi L. Lu *  \nAcademic Editor: Christos Papadimitriou  \nReceived: 16 December 2024  \nRevised: 18 February 2025  \nAccepted: 11 March 2025  \nPublished: 15 March 2025  \nCitation: Doddapaneni, R.; Tucker, J.D.; Lu, P.J.; Lu, Q.L. Synergistic Effect of Ribitol and Shikonin Promotes Apoptosis in Breast Cancer Cells. Int. J. Mol. Sci. 2025, 26, 2661. [https://](https://)[ ](https://)[doi.org/10.3390/ijms26062661](doi.org/10.3390/ijms26062661)  \n[Copyright:](Copyright:) © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \nMcColl-Lockwood Laboratory for Muscular Dystrophy Research, Cannon Research Center, Carolinas Medical Center, Atrium Health, Charlotte, NC 28203, USA  \n* Correspondence: [ravi.doddapaneni@atriumhealth.org](ravi.doddapaneni@atriumhealth.org) (R.D.); [qi.lu@atriumhealth.org](qi.lu@atriumhealth.org) (Q.L.L.)  \nAbstract: The mortality rate of breast cancer remains high, despite remarkable advancesin chemotherapy. Therefore, it is imperative to identify new treatment options. In the present study, we investigated whether the metabolite ribitol enhances the cytotoxic effect of shikonin against breast cancer in vitro. Here, we screened a panel of small molecules targeting energy metabolism against breast cancer. The results of the study revealed that ribitol enhances shikonin’s growth-inhibitory effects, with significant synergy. A significant (p \u003C 0.01) increase in the percentage (56%) of apoptotic cells was detected in the combined treatment group, compared to shikonin single-treatment group (38%), respectively. The combined ribitol and shikonin treatment led to significant arrest of cell proliferation (40%)(p \u003C 0.01) compared to untreated cells, as well as the induction of apoptosis. This was associated with upregulation of p53 (p \u003C 0.05) and downregulation of c-Myc (p \u003C 0.01), Bcl-xL (p \u003C 0.001), and Mcl-1 (p \u003C 0.05) . Metabolomic analysis supports the premise that inhibition of the Warburg effect is involved in shikonin-induced cell death, which is likely further enhanced by dysregulation of glycolysis and the tricarboxylic acid (TCA) cycle, afflicted by ribitol treatment. In conclusion, the present study demonstrates that themetabolite ribitol selectively enhances the cytotoxic effect mediated by shikonin against breast cancer in vitro.  \nKeywords: breast cancer; chemotherapy; shikonin; ribitol; metabolomics; drug synergy  \n1. Introduction  \nRecent research has primarily focused on investigating the potential of anti-cancer compounds to target specific molecular pathways involved in cancer progression [1–5] . These compounds have shown promising results in inhibiting tumor growth, reducing metastasis, and enhancing the sensitivity of cancer cells to chemotherapy. These therapeutic strategies show an enhanced anti-tumor effect, resulting in a notable improvement in survival rates. However, significant challenges persist in the field of drug therapy, including multi-drug resistance, poor response in certain breast cancer types, and undesirable dose-related side effects [6–11] . Therefore, the identification of agents that address these limitations and achieve synergistic effects with reduced doses of existing drugs becomes a desirable solution. Cancer cells are known to adapt their metabolism, such as their aerobic glycolysis (Warburg effect), to provide resistance to drugs, as well as to encourage cell survival and proliferation [12–16] . Thus, modulation of metabolism offers great potential to counter drug resistance and enhance efficacy.  \nWe previously reported that the pentose alcohol ribitol had the","cbCaigm1fGdaTUWm","https://ap.wps.com/l/cbCaigm1fGdaTUWm","pdf",5841191,18,"English","# Abstract\n# Introduction","[{\"question\":\"What was the main goal of the study?\",\"answer\":\"The study aimed to determine whether ribitol enhances the cytotoxic effect of shikonin against breast cancer cells in vitro and to assess the underlying mechanism of this synergy.\"},{\"question\":\"What evidence of synergy was reported?\",\"answer\":\"The combined ribitol and shikonin treatment significantly increased apoptosis percentages compared with shikonin alone and produced marked growth arrest relative to untreated cells.\"},{\"question\":\"Which molecular and metabolic changes were associated with the treatment?\",\"answer\":\"The study linked the effect to increased p53, decreased c-Myc and anti-apoptotic proteins such as Bcl-xL and Mcl-1, and metabolomic support for Warburg-effect inhibition alongside altered glycolysis and TCA cycle activity.\"}]","Synergistic Effect of Ribitol and Shikonin Promotes Apoptosis in Breast Cancer Cells | PDF",1790188286,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b6db8364e01ad7e0f786be5f9836c6e8.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2ebba671a68bb3d32c4a1ca5ed5a4d51.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0d44cf98b80a8bc72955696220d00447.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/51624895f75cc8b7c717e2104b0224f2.webp",980,1385]